BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 7
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4746)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.
Item 
Count 
PDF128
WORD25
HTML1952
Figures (1-3)465
Tables (1-5)402
 Sum=2972
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse337
Download1257
 Sum=1594
Jul 27, 2023 (publication date) through Oct 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1340-1353
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1340
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Survival comparisons between the combined hepatocellular and cholangiocarcinoma and hepatocellular carcinoma groups. A: Cumulative disease-free survival; B: Cumulative overall survival; C: Cumulative disease-free survival after propensity score matching; D: Cumulative oval survival after propensity score matching. HCC: Hepatocellular carcinoma; CC: Cholangiocarcinoma; HCC-CC: Hepatocellular carcinoma-cholangiocarcinoma.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Survival comparisons between the combined hepatocellular and cholangiocarcinoma and hepatocellular carcinoma groups of patients within the Milan criteria. A: Cumulative disease-free survival; B: Cumulative overall survival; C: Cumulative disease-free survival after propensity score matching; D: Cumulative oval survival after propensity score matching. HCC: Hepatocellular carcinoma; CC: Cholangiocarcinoma; HCC-CC: Hepatocellular carcinoma-cholangiocarcinoma.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Survival comparisons between the combined hepatocellular and cholangiocarcinoma and hepatocellular carcinoma groups of patients beyond the Milan criteria. A: Cumulative disease-free survival; B: Cumulative overall survival; C: Cumulative disease-free survival after propensity score matching; D: Cumulative oval survival after propensity score matching. HCC: Hepatocellular carcinoma; CC: Cholangiocarcinoma; HCC-CC: Hepatocellular carcinoma-cholangiocarcinoma.
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345